# Perimeter Solutions, Inc.: overview

PRM · NYSE · CIK 1880319 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/prm.md) · [Financials](/companies/prm/financials.md) · [Filings](/companies/prm/filings.md) · [Insiders](/companies/prm/insiders.md)

Latest reported revenue: [$213.8m](/filings/0001880319-26-000048.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Jul 31, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001880319-26-000048).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [288](/filings/0001880319-25-000129.md) | [86.2 d](/filings/0001880319-26-000013.md) | [72.0](/filings/0001880319-26-000037.md) | [163](/filings/0001880319-26-000048.md) | [315](/filings/0001880319-25-000129.md) | [103 d](/filings/0001880319-26-000013.md) | [125](/filings/0001880319-26-000037.md) | [214](/filings/0001880319-26-000048.md) |
| Gross margin | % | [62.8%](/filings/0001880319-25-000129.md) | [48.6% d](/filings/0001880319-26-000013.md) | [39.1%](/filings/0001880319-26-000037.md) | [62.4%](/filings/0001880319-26-000048.md) | [63.1%](/filings/0001880319-25-000129.md) | [45.2% d](/filings/0001880319-26-000013.md) | [40.6%](/filings/0001880319-26-000037.md) | [55.1%](/filings/0001880319-26-000048.md) |
| Operating margin | % | [(12.2%)](/filings/0001880319-25-000129.md) | [71.1% d](/filings/0001880319-26-000013.md) | [108.0%](/filings/0001880319-26-000037.md) | [(16.1%)](/filings/0001880319-26-000048.md) | [(27.7%)](/filings/0001880319-25-000129.md) | [(160.7%) d](/filings/0001880319-26-000013.md) | [58.0%](/filings/0001880319-26-000037.md) | [(95.0%)](/filings/0001880319-26-000048.md) |
| Net margin | % | [(30.9%)](/filings/0001880319-25-000129.md) | [167.2% d](/filings/0001880319-26-000013.md) | [78.7%](/filings/0001880319-26-000048.md) | [(19.8%)](/filings/0001880319-26-000048.md) | [(28.7%)](/filings/0001880319-25-000129.md) | [(136.5%) d](/filings/0001880319-26-000013.md) | [58.3%](/filings/0001880319-26-000048.md) | [(85.0%)](/filings/0001880319-26-000048.md) |
| Diluted EPS | $ per share | [(0.61)](/filings/0001880319-25-000129.md) | not reported | [0.36](/filings/0001880319-26-000037.md) | [(0.22)](/filings/0001880319-26-000048.md) | [(0.62)](/filings/0001880319-25-000129.md) | not reported | [0.44](/filings/0001880319-26-000037.md) | [(1.11)](/filings/0001880319-26-000048.md) |
| Free cash flow | $m | [179 d](/filings/0001880319-25-000129.md) | [(12.4) d](/filings/0001880319-26-000013.md) | [18.9](/filings/0001880319-26-000037.md) | [(15.6) d](/filings/0001880319-26-000048.md) | [194 d](/filings/0001880319-25-000129.md) | [11.6 d](/filings/0001880319-26-000013.md) | [(94.8)](/filings/0001880319-26-000037.md) | [(13.4) d](/filings/0001880319-26-000048.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY (2020-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [340](/filings/0001880319-23-000026.md) | [361](/filings/0001880319-25-000021.md) | [322](/filings/0001880319-26-000013.md) | [561](/filings/0001880319-26-000013.md) | [653](/filings/0001880319-26-000013.md) |
| Gross margin | % | [47.7%](/filings/0001880319-23-000026.md) | [35.7%](/filings/0001880319-25-000021.md) | [39.8%](/filings/0001880319-26-000013.md) | [56.5%](/filings/0001880319-26-000013.md) | [57.5%](/filings/0001880319-26-000013.md) |
| Operating margin | % | [21.0%](/filings/0001880319-23-000026.md) | [36.1%](/filings/0001880319-25-000021.md) | [29.3%](/filings/0001880319-26-000013.md) | [(0.7%)](/filings/0001880319-26-000013.md) | [(30.8%)](/filings/0001880319-26-000013.md) |
| Net margin | % | [7.1%](/filings/0001880319-23-000026.md) | [25.5%](/filings/0001880319-25-000021.md) | [21.0%](/filings/0001880319-26-000013.md) | [(1.1%)](/filings/0001880319-26-000013.md) | [(31.6%)](/filings/0001880319-26-000013.md) |
| Diluted EPS | $ per share | [0.46](/filings/0001880319-23-000026.md) | [0.52](/filings/0001880319-25-000021.md) | [0.41](/filings/0001880319-26-000013.md) | [(0.04)](/filings/0001880319-26-000013.md) | [(1.37)](/filings/0001880319-26-000013.md) |
| Free cash flow | $m | [63.3](/filings/0001880319-23-000026.md) | [(48.8)](/filings/0001880319-25-000021.md) | [(9.2)](/filings/0001880319-26-000013.md) | [173](/filings/0001880319-26-000013.md) | [209](/filings/0001880319-26-000013.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/prm/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [WINDACRE PARTNERSHIP LLC](/funds/1599383.md) | 2026-06-30 | $575.7m | 16,148,621 |  | Reduced −5,705,979 |
| [PRINCIPAL FINANCIAL GROUP INC](/funds/1126328.md) | 2026-06-30 | $499.4m | 14,007,326 |  | Added +1,494,167 |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $433.9m | 12,170,113 |  | Added +1,340,733 |
| [FMR LLC](/funds/315066.md) | 2026-06-30 | $342.3m | 9,602,473 |  | Added +563,363 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $234.8m | 6,587,147 |  | Added +411,660 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $153.8m | 4,315,745 |  | Reduced −447,720 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $150.8m | 4,230,528 |  | Added +433,923 |
| [Jupiter Topco LLC](/funds/2146052.md) | 2026-06-30 | $147.1m | 4,125,974 |  | Not compared |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $128.7m | 3,611,344 |  | Added +367,276 |
| [DF DENT & CO INC](/funds/934999.md) | 2026-06-30 | $118.5m | 3,322,708 |  | Reduced −609,663 |

## Recent filings

[All 335 filings](/companies/prm/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-07-31 | 09:28 ET | [10-Q](/filings/0001880319-26-000048.md) | Quarterly report, period 2026-06-30 | 0001880319-26-000048 |
| 2026-07-31 | 07:35 ET | [8-K](/filings/0001880319-26-000044.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001880319-26-000044 |
| 2026-05-28 | 13:37 ET | [8-K](/filings/0001880319-26-000039.md) | 5.07 Shareholder vote results | 0001880319-26-000039 |
| 2026-05-06 | 09:22 ET | [10-Q](/filings/0001880319-26-000037.md) | Quarterly report, period 2026-03-31 | 0001880319-26-000037 |
| 2026-05-06 | 06:44 ET | [8-K](/filings/0001880319-26-000035.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001880319-26-000035 |
| 2026-04-17 | 08:48 ET | [DEF 14A](/filings/0001880319-26-000023.md) | Proxy statement, period 2026-05-28 | 0001880319-26-000023 |
| 2026-03-10 | 18:12 ET | [SCHEDULE 13D](/filings/0001493152-26-009589.md) | Ownership report, active investor | 0001493152-26-009589 |
| 2026-02-26 | 09:53 ET | [10-K](/filings/0001880319-26-000013.md) | Annual report, period 2025-12-31 | 0001880319-26-000013 |
| 2026-02-26 | 08:09 ET | [8-K](/filings/0001880319-26-000010.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001880319-26-000010 |
| 2026-01-22 | 17:16 ET | [8-K](/filings/0001493152-26-003264.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-003264 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001880319-26-000013.md), filed Feb 26, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/a4e28076-b149-4322-829d-8e79f0e30793)

## About the filer

- CIK: 1880319
- Tickers: PRM
- Exchange: NYSE
- SIC code: 2800 Chemicals & Allied Products
- State of incorporation: not reported
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.